OMEROS CORP Operating Expenses
OMEROS CORP (OMER) reported Operating Expenses of $41.02 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-05-09
- OMEROS CORP operating expenses for the quarter ending 2019-03-31 was $41.02M, a 40.10% increase year-over-year.
- OMEROS CORP operating expenses for the quarter ending 2018-12-31 was $40.49M, a 45.23% increase year-over-year.
- OMEROS CORP operating expenses for the quarter ending 2018-09-30 was $40.05M, a 49.62% increase year-over-year.
- OMEROS CORP operating expenses for the quarter ending 2018-06-30 was $32.27M, a 10.94% increase year-over-year.
- OMEROS CORP operating expenses for fiscal 2018 was $142.09M, a 30.69% increase from fiscal 2017.
- OMEROS CORP operating expenses for fiscal 2017 was $108.72M, a 13.38% increase from fiscal 2016.
- OMEROS CORP operating expenses for fiscal 2016 was $95.89M, a 13.15% increase from fiscal 2015.
- OMEROS CORP operating expenses for fiscal 2015 was $84.75M, a 20.13% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 204 month | Operating Expenses 207 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | $41.02M 10-Q · filed 2019-05-09 | $81.51M derived: sum of 2 quarters · filed 2019-05-09 | $121.56M derived: sum of 3 quarters · filed 2019-05-09 | $153.83M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2018-12-31 | $40.49M 10-K · filed 2019-03-01 | $80.54M derived: sum of 2 quarters · filed 2019-03-01 | $112.81M derived: sum of 3 quarters · filed 2019-03-01 | $142.09M 10-K · filed 2019-03-01 | ||
| 2018-09-30 | $40.05M 10-K · filed 2019-03-01 | $72.32M derived: sum of 2 quarters · filed 2019-03-01 | $101.60M 10-Q · filed 2018-11-08 | $129.48M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2018-06-30 | $32.27M 10-K · filed 2019-03-01 | $61.55M 10-Q · filed 2018-08-09 | $89.43M derived: sum of 3 quarters · filed 2019-05-09 | $116.20M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2018-03-31 | $29.28M 10-Q · filed 2019-05-09 | $57.16M derived: sum of 2 quarters · filed 2019-05-09 | $83.93M derived: sum of 3 quarters · filed 2019-05-09 | $113.02M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $27.88M 10-K · filed 2019-03-01 | $54.65M derived: sum of 2 quarters · filed 2019-03-01 | $83.74M derived: sum of 3 quarters · filed 2019-03-01 | $108.72M 10-K · filed 2019-03-01 | ||
| 2017-09-30 | $26.77M 10-K · filed 2019-03-01 | $55.86M derived: sum of 2 quarters · filed 2019-03-01 | $80.84M 10-Q · filed 2018-11-08 | $105.60M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $29.09M 10-K · filed 2019-03-01 | $54.07M 10-Q · filed 2018-08-09 | $78.83M derived: sum of 3 quarters · filed 2019-03-01 | $102.16M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $24.98M 10-K · filed 2019-03-01 | $49.74M derived: sum of 2 quarters · filed 2019-03-01 | $73.07M derived: sum of 3 quarters · filed 2019-03-01 | $94.00M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | $24.76M 10-K · filed 2018-03-01 | $48.09M derived: sum of 2 quarters · filed 2018-03-01 | $69.02M derived: sum of 3 quarters · filed 2018-03-01 | $95.89M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | $23.33M 10-K · filed 2018-03-01 | $44.26M derived: sum of 2 quarters · filed 2018-03-01 | $71.13M 10-Q · filed 2017-11-09 | $95.85M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | $20.93M 10-K · filed 2018-03-01 | $47.80M 10-Q · filed 2017-08-08 | $72.52M derived: sum of 3 quarters · filed 2018-03-01 | $95.08M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | $26.87M 10-K · filed 2018-03-01 | $51.59M derived: sum of 2 quarters · filed 2018-03-01 | $74.15M derived: sum of 3 quarters · filed 2018-03-01 | $93.30M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $24.71M 10-K · filed 2017-03-16 | $47.27M derived: sum of 2 quarters · filed 2017-03-16 | $66.43M derived: sum of 3 quarters · filed 2017-03-16 | $84.75M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $22.56M 10-K · filed 2017-03-16 | $41.71M derived: sum of 2 quarters · filed 2017-03-16 | $60.03M 10-Q · filed 2016-11-09 | $80.19M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $19.15M 10-K · filed 2017-03-16 | $37.47M 10-Q · filed 2016-08-09 | $57.63M derived: sum of 3 quarters · filed 2017-03-16 | $74.97M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | $18.32M 10-K · filed 2017-03-16 | $38.47M derived: sum of 2 quarters · filed 2017-03-16 | $55.82M derived: sum of 3 quarters · filed 2017-03-16 | $73.08M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | $20.16M 10-K · filed 2016-03-15 | $37.50M derived: sum of 2 quarters · filed 2016-03-15 | $54.76M derived: sum of 3 quarters · filed 2016-03-15 | $70.55M 10-K · filed 2017-03-16 | ||
| 2014-09-30 | $17.35M 10-K · filed 2016-03-15 | $34.61M derived: sum of 2 quarters · filed 2016-03-15 | $50.39M 10-Q · filed 2015-11-09 | $64.46M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | $17.26M 10-K · filed 2016-03-15 | $33.05M 10-Q · filed 2015-08-10 | $47.12M derived: sum of 3 quarters · filed 2016-03-15 | $60.75M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-03-31 | $15.78M 10-K · filed 2016-03-15 | $29.86M derived: sum of 2 quarters · filed 2016-03-15 | $43.48M derived: sum of 3 quarters · filed 2016-03-15 | $56.78M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2013-12-31 | $14.07M 10-K · filed 2015-03-16 | $27.70M derived: sum of 2 quarters · filed 2015-03-16 | $41.00M derived: sum of 3 quarters · filed 2015-03-16 | $52.12M 10-K · filed 2016-03-15 | ||
| 2013-09-30 | $13.63M 10-K · filed 2015-03-16 | $26.93M derived: sum of 2 quarters · filed 2015-03-16 | $38.05M 10-Q · filed 2014-11-10 | $47.16M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | $13.30M 10-K · filed 2015-03-16 | $24.41M 10-Q · filed 2014-08-11 | $33.53M derived: sum of 3 quarters · filed 2015-03-16 | $47.98M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | $11.12M 10-K · filed 2015-03-16 | $20.23M derived: sum of 2 quarters · filed 2015-03-16 | $34.68M derived: sum of 3 quarters · filed 2015-03-16 | $44.45M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | $9.12M 10-K · filed 2014-03-13 | $23.57M derived: sum of 2 quarters · filed 2014-03-13 | $33.34M derived: sum of 3 quarters · filed 2014-03-13 | $42.91M 10-K · filed 2015-03-16 | ||
| 2012-09-30 | $14.45M 10-K · filed 2014-03-13 | $24.22M derived: sum of 2 quarters · filed 2014-03-13 | $33.79M 10-Q · filed 2013-11-07 | $44.78M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-06-30 | $9.77M 10-K · filed 2014-03-13 | $19.34M 10-Q · filed 2013-08-09 | $30.33M derived: sum of 3 quarters · filed 2014-03-13 | $37.48M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-03-31 | $9.57M 10-K · filed 2014-03-13 | $20.56M derived: sum of 2 quarters · filed 2014-03-13 | $27.71M derived: sum of 3 quarters · filed 2014-03-13 | $33.81M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2011-12-31 | $10.99M 10-K · filed 2013-03-18 | $18.14M derived: sum of 2 quarters · filed 2013-03-18 | $24.25M derived: sum of 3 quarters · filed 2013-03-18 | $31.93M 10-K · filed 2014-03-13 | ||
| 2011-09-30 | $7.15M 10-K · filed 2013-03-18 | $13.26M derived: sum of 2 quarters · filed 2013-03-18 | $20.94M 10-Q · filed 2012-11-09 | $30.48M derived: sum of 4 quarters · filed 2013-03-18 | $180.97M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $6.10M 10-K · filed 2013-03-18 | $13.79M 10-Q · filed 2012-08-07 | $23.33M derived: sum of 3 quarters · filed 2013-03-18 | $31.07M derived: sum of 4 quarters · filed 2013-03-18 | $173.81M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $7.69M 10-K · filed 2013-03-18 | $17.22M derived: sum of 2 quarters · filed 2013-03-18 | $24.97M derived: sum of 3 quarters · filed 2013-03-18 | $33.10M derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2010-12-31 | $9.53M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $17.28M derived: sum of 2 quarters · filed 2013-03-18 | $25.41M derived: sum of 3 quarters · filed 2013-03-18 | $32.21M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $7.74M 10-Q · filed 2011-11-08 | $15.88M derived: sum of 2 quarters · filed 2011-11-08 | $22.68M 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | $8.13M 10-Q · filed 2011-08-09 | $14.93M 10-Q · filed 2011-08-09 | ||||
| 2009-12-31 | $22.20M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |